Non-pharmacological Management of Cardiac Arrest

Cardiac arrest is the cessation of cardiac mechanical activity, as confirmed by the absence of signs of circulation [1]. It represents a serious worldwide public health concern [1, 2]. In the United States, the incidence of out-of-hospital cardiac arrest (OHCA) in adults is about 141 per 100,000 people (347,322 per year) while in-hospital cardiac arrest (IHCA) is near 1.99 per 1000 hospitalization days. Millions more occur across the rest of North America, Europe, and Asia [2, 3]. While global survival after OHCA has significantly increased in the past 40 years, it remains unacceptably low at hospital discharge, accounting of 8.8% (95% confidence interval (CI), 8.2–9.4%) [4]. Survival at hospital discharge does not exceed 20% in IHCA according to the actual largest studies [5].